Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5014657 | 0.87 | SLC6A4 (0.35) | SLC6A4SLC6A2SLC6A3HTR2AKCNH2 | |
| SCHEMBL2683313 | 0.85 | CYP1A2 (0.37) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL5022865 | 0.80 | MAPK1 (0.34) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL5015066 | 0.79 | ALDH1A1 (0.34) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL5022863 | 0.79 | CYP1A2 (0.33) | CYP1A2CYP2D6MAPK1 | |
| SCHEMBL21652642 | 0.77 | SLC6A4 (0.37) | SLC6A4SLC6A2SLC6A3HSP90AB1CYP1A2 | |
| SCHEMBL14036774 | 0.75 | GAA (0.51) | SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL5015113 | 0.73 | KCNA5 (0.42) | — | |
| SCHEMBL14036680 | 0.73 | SLC6A4 (0.43) | SLC6A4SLC6A2SLC6A3CYP1A2CYP2D6 | |
| SCHEMBL5014685 | 0.73 | LMNA (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008137102-A2 | METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR | TORREYPINES THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008137102-A2 | METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR | TORREYPINES THERAPEUTICS, INC. (US) | 2008-11-13 | — | — | WO | disclosed |